Aimei Health Technology Co., Ltd (AFJK)
US — Financial Services Sector
Automate Your Wheel Strategy on AFJK
With Tiblio's Option Bot, you can configure your own wheel strategy including AFJK - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol AFJK
- Rev/Share 0.0
- Book/Share 10.5122
- PB 0.8676
- Debt/Equity 0.0394
- CurrentRatio 0.009
- ROIC -0.0223
- MktCap 55830205.0
- FreeCF/Share -0.1794
- PFCF -77.8665
- PE 25.9226
- Debt/Assets 0.0364
- DivYield 0
- ROE 0.0285
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 1
- P/B Score 3
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
About Aimei Health Technology Co., Ltd (AFJK)
- IPO Date
- Website None
- Industry Shell Companies
- CEO Junheng Xie
- Employees 2
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.